Treatment of hepatocellular carcinoma.
Institute of Clinical Surgery, University of Verona, Italy.
N
N
Nicoli
L
L
Marchiori
G C
GC
Mansueto
G
G
Morana
A
A
Bellini
F
F
Musajo
L
L
Bortolasi
I
I
Dal Dosso
V
V
Costa
P
P
Pederzoli
D000081:Acetamides / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000601:surgery / Q000628:therapy*; D002404:Catheterization; D016461:Chemoembolization, Therapeutic; D004621:Embolization, Therapeutic / Q000379:methods; D005260:Female; D006498:Hepatectomy / Q000379:methods; D006499:Hepatic Artery; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage; D015996:Survival Rate
D000081:Acetamides; D008937:Mitomycins; C081524:N,N'-diacetyl-1,6-diaminohexane; D007459:Iodized Oil